Palatin Technologies, Inc. To Report Fiscal Year 2013 Third Quarter Results; Teleconference and Webcast to be held on May 14, 2013
Teleconference to Include Update on Development of Bremelanotide for Female Sexual Dysfunction
CRANBURY, N.J., May 8, 2013 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN) will announce its third quarter, fiscal year 2013 financial results on Tuesday, May 14, 2013 before the open of the U.S. financial markets.
Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on May 14, 2013. The conference call will include an update on development of bremelanotide for female sexual dysfunction, including plans for Phase 3 clinical trials and results of the end-of-Phase 2 meeting with the U.S. Food and Drug Administration.
|
Schedule for the Financial Results Press Release, Conference Call / Webcast | |
|
5/14/2013 at 7:30 a.m. ET
|
|
5/14/2013 at 11:00 a.m. ET 1-888-427-9419 1-719-457-2648 8591699 |
|
5/14/2013-5/21/2013 1-888-203-1112 1-719-457-0820 8591699 |
|
http://www.palatin.com |
|
The webcast and replay can be accessed by logging on to the "Investor/Media Center-Webcasts" section of Palatin's website at http://www.palatin.com | |
About Palatin Technologies, Inc.
Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. For additional information, please visit http://www.palatin.com or follow us on Twitter at http://twitter.com/PalatinTech.
SOURCE Palatin Technologies, Inc.
RELATED LINKS
http://www.palatin.com
More by this Source
Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2013 Results
Sep 30, 2013, 17:18 ET
Palatin Technologies, Inc. To Report Fiscal Year 2013 Fourth Quarter Results
Sep 25, 2013, 16:32 ET
Palatin Technologies Announces Third Quarter Fiscal Year 2013 Results and Update on Development of Bremelanotide for Female Sexual Dysfunction
May 14, 2013, 07:30 ET
Featured Video
Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.
- Site Preview
-
Close Site Preview
-
View FullScreen
